Leibniz-IPF, Ivan Minev
New era of cyborganics – Prof. Ivan Minev receives ERC Consolidator Grant
30.11.2023
Over the next five years, the ERC will provide two million euro of funding for the development of a new class of electronic components that consist almost entirely of water and could make the interface between biological tissue and machine seamless.
Laboratory equipment – fit for the future with more sustainability
30.11.2023
Laboratory equipment manufacturers need to focus more and more on sustainability. On the one hand, saving resources and energy is a cost factor in production and therefore economically important for these companies.
Vincent Hoban, University College Dublin
World’s first commercial deployment of novel soft X-ray microscope
03.11.2023
SiriusXT Ltd, an Irish technology SME, announced the world’s first commercial deployment of the SXT-100, the company’s unique table-top Soft X-ray Microscope with applications in disease research and the drug discovery process, at the UCD Conway Institute of Biomolecular and Biomedical Research at University College Dublin.
Karin Kaiser / MHH
More impact against cancer
04.09.2023
MHH molecular physician Professor Dr. Dr. Schambach wants to use genetically modified natural killer cells to find new therapeutic options against three particularly malignant cancers. The EU is funding the project with 3.8 million euros
monkeybusiness
Pandemic prevention: progress in research infrastructure
15.08.2023
The Covid-19 pandemic has clearly shown that there is still a lot of potential in research structures and funding to better manage a pandemic. Prevention plays just as important a role as dealing with the pandemic. Technological measures that can facilitate virus detection or help to analyze the course in more detail need to be developed.
Anna Schroll/Leibniz-HKI
Robotics: modular platform for antibiotics research
27.07.2023
The high cost and limited commercial value of new antibiotics discourage their development, as they are used sparingly to avoid resistance. To address this, a new robotics platform aims to simplify the development of active substances to combat the problem of antibiotic resistance. While we cannot always prevent resistance, this approach offers a promising solution.
svitlanah
BioDevCenter: biologicals are the future of medicine
27.04.2023
Not all advances in medical technology immediately catch your eye – take biologicals, for example. These are molecules that are biotechnologically designed for a specific application. In the German state of Baden-Württemberg, the Biologicals Development Center (BioDevCenter) and its infrastructure aim to bring them to market faster in the future.
Max Planck Institute for Molecular Biomedicine
Microelectrode array: hammock for brain organoids
20.04.2023
Novel microelectrode array system enables long-term cultivation and electrophysiological analyses of brain organoids.
BLINK DX
BLINK DX: revolutionizing digital PCR
11.04.2023
The polymerase chain reaction, or PCR, plays a major role both in the diagnosis of infectious diseases and in research. Since the onset of the COVID-19 pandemic, the term has become widely known. At MEDICA 2022, the BLINK AG from Jena, Germany, presented the BLINK Beads, a technology that is bound to revolutionize the applications of PCR.
Max-Planck-Institut für medizinische Forschung
Further advance in super-resolution fluorescence microscopy
16.03.2023
Scientists led by Nobel Laureate Stefan Hell at the Max Planck Institute for Medical Research in Heidelberg have developed a super-resolution microscope with a spatio-temporal precision of one nanometer per millisecond.
ckstockphoto
Smart microscopy works out where to take the picture
16.03.2023
Researchers at Lund University in Sweden have now developed a software solution for smart, data-driven microscopy, which makes this possible.